Latanoprost/Timolol Arrow

Timolol maleate and latanoprost, the active ingredients in Latanoprost/Timolol Arrow, are a prostaglandin analog and beta‑blocker combination presented as a sterile ophthalmic solution eye drops for ocular use. The formulation contains 0.005% latanoprost and 0.5% timolol maleate and is intended for once‑daily administration to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost/Timolol Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, ophthalmology clinics and procurement teams worldwide, ensuring quality‑assured products that meet EU regulatory standards.

Latanoprost/Timolol Arrow is used in the management of ocular conditions characterized by elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers pressure to prevent conversion to glaucoma. Secondary open‑angle glaucoma: provides combined pressure‑lowering action when monotherapy is insufficient.

Latanoprost/Timolol Arrow may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation - Transient blurred vision - Conjunctival hyperemia (redness) - Increased eyelash length or density - Darkening of the iris or peri‑ocular skin - Mild headache

Serious or Rare Side Effects: - Severe allergic reaction (angio‑edema, anaphylaxis) - Worsening of glaucoma or sudden loss of vision - Chest pain or myocardial ischemia - Bradycardia or marked hypotension - Persistent eye pain or ulceration - Acute anterior uveitis

Before prescribing Latanoprost/Timolol Arrow, clinicians should consider several safety aspects.

Assess baseline intra‑ocular pressure: ensure appropriate monitoring after initiation. Screen for asthma or chronic obstructive pulmonary disease: beta‑blocker component may exacerbate bronchospasm. Monitor heart rate and blood pressure: timolol can cause bradycardia or hypotension. Avoid use in patients with known sulfonamide allergy: timolol maleate contains a sulfonamide moiety. Do not combine with other prostaglandin analog eye drops: risk of additive ocular effects. Store at room temperature: keep bottle tightly capped, protect from light and freezing.

Latanoprost/Timolol Arrow can interact with systemic and ocular medications.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): additive bradycardia/hypotension. - Other intra‑ocular pressure‑lowering agents (e.g., carbonic anhydrase inhibitors): risk of excessive pressure reduction. - Sympathomimetic agents (e.g., epinephrine eye drops): may diminish timolol efficacy.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: possible reduced ocular absorption. - CYP2D6 inhibitors (e.g., fluoxetine): may increase timolol plasma levels. - NSAIDs used topically: potential for corneal irritation when combined.